FFNCX | VSCGX | FFNCX / VSCGX | |
Total Expense Ratio | 1.53 | 0.12 | 1,275% |
Annual Report Gross Expense Ratio | 1.53 | 0.12 | 1,275% |
Fund Existence | 18 years | 31 years | - |
Gain YTD | 6.660 | 7.162 | 93% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | 500 | N/A | - |
Net Assets | 2.3B | 10.5B | 22% |
Annual Yield % from dividends | 1.61 | 3.03 | 53% |
Returns for 1 year | 9.02 | 5.63 | 160% |
Returns for 3 years | 18.48 | 14.51 | 127% |
Returns for 5 years | 18.17 | 9.13 | 199% |
Returns for 10 years | 36.24 | 37.31 | 97% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
SHPCX | 12.96 | 0.07 | +0.54% |
Saratoga Health & Biotechnology C | |||
SHSCX | 45.89 | 0.22 | +0.48% |
BlackRock Health Sciences Opps Inv C | |||
TLASX | 12.13 | 0.05 | +0.41% |
Transamerica Large Core ESG R6 | |||
FCUDX | 20.11 | 0.08 | +0.40% |
NYLI PineStone U.S. Equity Class R6 | |||
NSGAX | 23.16 | 0.07 | +0.30% |
Columbia Select Large Cap Equity A |